1. FRI0150 GS-9876, A NOVEL, HIGHLY SELECTIVE, SYK INHIBITOR IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: SAFETY, TOLERABILITY AND EFFICACY RESULTS OF A PHASE 2 STUDY. (June 2019) Authors: Kivitz, Alan; Mehta, Daksha; Matzkies, Franziska; Mozaffarian, Afsaneh; Kunder, Rebecca; DI Paolo, Julie A.; Mozaffarian, Neelufar; Hsueh, Sean; Kim, Jiyun; Jiang, Wendy; Liu, Lin; Sundy, John; Genovese, Mark C. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 746 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Issue 2 (5th May 2012) Authors: Buttgereit, Frank; Mehta, Daksha; Kirwan, John; Szechinski, Jacek; Boers, Maarten; Alten, Rieke E; Supronik, Jerzy; Szombati, Istvan; Romer, Ulrike; Witte, Stephan; Saag, Kenneth G Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 2(2013) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗